The Food and Drug Administration is expanding their investigation into drugs involved in a Meningitis outbreak, they announced on Monday.
The FDA said it received reports of three new cases of Meningitis infections tied to products made by the New England Compounding Center.
These first involved the steroid triamcinolone, a different steroid than was implicated in the existing Meningitis case.
The other two new cases involve medication injected into coronary arteries during open heart surgery and heart transplant surgery.
As a result, the FDA said doctors should alert patients given any injectable drug made by the New England Compounding Center, saying, "Out of significant concern and out of an abundance of caution, patients who received these products should be alerted to the potential risk of infection."
WFMY News 2